SNDX | | Syndax Pharmaceuticals Inc | Katkin Keith | Director | Oct 06, 2022 | Option Exercise | $17.05 | 59,798 | 1,019,588 | 52,782 | Oct 07, 2022, 04:05 PM |
SNDX | | Syndax Pharmaceuticals Inc | Katkin Keith | Director | Sep 30, 2022 | Option Exercise | $16.57 | 7,122 | 118,017 | 34,914 | Oct 04, 2022, 05:49 PM |
SNDX | | Syndax Pharmaceuticals Inc | Katkin Keith | Director | Oct 03, 2022 | Option Exercise | $16.48 | 360 | 5,932 | 32,167 | Oct 04, 2022, 05:49 PM |
SNDX | | Syndax Pharmaceuticals Inc | Katkin Keith | Director | Oct 04, 2022 | Option Exercise | $16.77 | 720 | 12,071 | 32,223 | Oct 04, 2022, 05:49 PM |
UROV | | Urovant Sciences Ltd. | Katkin Keith | PEO;CEO/Urovant Sciences, Inc. | Feb 19, 2020 | Option Exercise | $8.47 | 360,000 | 3,049,200 | 379,680 | Feb 21, 2020, 06:42 PM |
UROV | | Urovant Sciences Ltd. | Katkin Keith | PEO;CEO/Urovant Sciences, Inc. | Dec 09, 2019 | Option Exercise | $8.32 | 240,000 | 1,996,800 | 120,000 | Dec 11, 2019, 05:01 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Dec 15, 2014 | Sale | $9.65 | 410,320 | 3,961,359 | 1,171,929 | Dec 18, 2014, 08:52 AM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Dec 17, 2014 | Sale | $16.93 | 62,520 | 1,058,464 | 914,249 | Dec 18, 2014, 08:52 AM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Oct 24, 2014 | Sale | $11.76 | 27,567 | 324,188 | 732,845 | Oct 24, 2014, 08:34 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Aug 01, 2014 | Sale | $5.26 | 9,670 | 50,864 | 760,412 | Aug 01, 2014, 08:44 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | May 28, 2014 | Sale | $5.01 | 442,212 | 2,215,482 | 750,082 | May 30, 2014, 08:00 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Dec 18, 2013 | Sale | $2.67 | 29,515 | 78,935 | 445,707 | Dec 20, 2013, 05:24 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Nov 01, 2013 | Sale | $4.14 | 4,385 | 18,138 | 475,222 | Nov 05, 2013, 08:00 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Aug 02, 2013 | Sale | $4.84 | 15,500 | 74,981 | 479,607 | Aug 02, 2013, 07:58 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | May 15, 2013 | Option Exercise | $2.12 | 465,876 | 986,369 | 710,545 | May 17, 2013, 08:02 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Jun 25, 2012 | Option Exercise | $0.73 | 190,125 | 138,015 | 411,557 | Dec 19, 2012, 04:48 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Dec 03, 2012 | Sale | $2.55 | 18,250 | 46,457 | 119,482 | Dec 05, 2012, 04:39 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Jun 25, 2012 | Sale | $3.50 | 190,125 | 664,791 | 137,732 | Jun 27, 2012, 05:00 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Mar 06, 2012 | Buy | $2.61 | 10,000 | 26,093 | 327,857 | Mar 07, 2012, 09:00 AM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Dec 02, 2011 | Sale | $2.37 | 17,495 | 41,421 | 190,857 | Dec 06, 2011, 05:01 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Nov 17, 2011 | Option Exercise | $1.73 | 218,024 | 377,682 | 317,364 | Nov 18, 2011, 08:01 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Nov 16, 2011 | Sale | $1.56 | 218,026 | 340,077 | 317,365 | Nov 18, 2011, 08:01 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Dec 02, 2010 | Sale | $2.31 | 390,600 | 900,763 | 403,652 | Dec 03, 2010, 08:55 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Nov 01, 2010 | Sale | $5.70 | 20,000 | 114,000 | 145,852 | Nov 02, 2010, 09:55 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Sep 13, 2010 | Option Exercise | $2.70 | 1,321 | 3,567 | 165,852 | Sep 15, 2010, 06:09 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Sep 01, 2010 | Sale | $2.83 | 62,874 | 177,864 | 167,173 | Sep 02, 2010, 04:30 PM |
AVNR | | AVANIR PHARMACEUTICALS, INC. | Katkin Keith | President and CEO | Aug 31, 2010 | Sale | $2.86 | 40,000 | 114,512 | 230,047 | Sep 02, 2010, 04:30 PM |